Source: Antisense Therapeutics/LinkedIn
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Antisense Therapeutics (ANP) submits its first clinical trial application for the Phase 2b/3 clinical trial of its drug aiming to treat muscular dystrophy
  • The application has been submitted to the Federal Institute for Drugs and Medical Devices in Germany for evaluation and approval
  • The company says the submission is a milestone moment as it works to establish a regulatory pathway with the European Medicines Agency
  • It is working to optimise its capital management process for the drug’s development to ensure effective use of its existing cash reserves
  • Shares are trading 1.20 per cent higher today at 8.4 cents each at 11:20 am AEST.

Antisense Therapeutics (ANP) has submitted its first clinical trial application for the Phase 2b/3 clinical trial of ATL1102.

ATL1102 aims to treat patients with muscular dystrophy who are unable to walk.

The application was submitted to the Federal Institute for Drugs and Medical Devices in Germany for evaluation and approval.

The company said the application submission was a milestone moment as it works to establish a regulatory pathway with the European Medicines Agency.

Antisense has been working to optimise its capital management process for the drug’s development to ensure effective use of its existing cash reserves.

Shares were trading 1.20 per cent higher today at 8.4 cents each at 11:20 am AEST.

ANP by the numbers
More From The Market Online

Week 13 Wrap: Easter bunny delivers new all time high for ASX200

Another week, another all time high. The ASX200 clocked 7,901pts on Thursday for the first time…
The Market Online Video

Market Close: Green lights up on ASX for Easter hunt go

The ASX200 closed the day in record territory - nearly a per cent up with every…

Market shrugs as Fisher & Paykel announces mass recall

Fisher & Paykel has initiated a voluntary limited recall of batches of Airvo 1 and my…
The Market Online Video

Market Update: ASX glows red hot with another hit record

The ASX200 is trading up, hitting a new high of 7901 point and eclipsing the last…